The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 23, 2022

Filed:

May. 29, 2018
Applicant:

Brenda K. Mann, Salt Lake City, UT (US);

Inventor:

Brenda K. Mann, Salt Lake City, UT (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/38 (2006.01); A61K 9/00 (2006.01); A61K 47/34 (2017.01); A61K 45/06 (2006.01); A61P 31/04 (2006.01); A61P 15/02 (2006.01); A61K 47/32 (2006.01); A61K 31/565 (2006.01);
U.S. Cl.
CPC ...
A61K 47/38 (2013.01); A61K 9/0034 (2013.01); A61K 45/06 (2013.01); A61K 47/32 (2013.01); A61K 47/34 (2013.01); A61P 15/02 (2018.01); A61P 31/04 (2018.01); A61K 31/565 (2013.01);
Abstract

The vaginal hydrogel may be a composition which includes a glycosaminoglycan, a reactive molecule, and, in some embodiments, a therapeutic agent. The glycosaminoglycan and the reactive molecule may include either thiol groups or thiol reactive sites and have a pH that is within a range of a normal vaginal environment. Some of the thiol groups may interact with the vaginal mucosa and allow the hydrogel to remain in the vagina for a longer period than existing compounds intended for intravaginal administration. Therapeutic agents may be included in the composition. In these embodiments, the hydrogel acts as a vehicle which delivers the therapeutic agent.


Find Patent Forward Citations

Loading…